Jay M. Short Ph.D., Chief Executive Officer at BioAtla, Inc. (BCAB), sold 129,263 shares at $39.22 ($5.1M) on 2021-06-17, disclosed to the SEC on 2021-06-22.
Open-market sale of $5.1M BCAB by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.22 | 19,269 | $756K | 14.9% |
| 2 | $39.22 | 19,269 | $756K | 14.9% |
| 3 | $38.24 | 17,575 | $672K | 13.2% |
| 4 | $39.54 | 35,725 | $1.4M | 27.8% |
| 5 | $39.54 | 35,725 | $1.4M | 27.8% |
| 6 | $39.89 | 1,700 |
| $68K |
| 1.3% |
| Total | $39.27 avg | 129,263 | $5.1M | 100% |
| Filing → |
| BCAB | BUY | 2022-08-15 | $207K | — | Filing → |
| BCAB | BUY | 2022-06-23 | $397K | — | Filing → |
| BCAB | SELL | 2021-12-07 | $2.1M | — | Filing → |